EP1216319B1 - Absorptive fabric - Google Patents

Absorptive fabric Download PDF

Info

Publication number
EP1216319B1
EP1216319B1 EP20000960844 EP00960844A EP1216319B1 EP 1216319 B1 EP1216319 B1 EP 1216319B1 EP 20000960844 EP20000960844 EP 20000960844 EP 00960844 A EP00960844 A EP 00960844A EP 1216319 B1 EP1216319 B1 EP 1216319B1
Authority
EP
European Patent Office
Prior art keywords
yarn
gel
fabric
forming
method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP20000960844
Other languages
German (de)
French (fr)
Other versions
EP1216319A1 (en
Inventor
John Overton Hudson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BHK Holding Ltd
Original Assignee
BHK Holding Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US40649099A priority Critical
Priority to US406490 priority
Priority to US61203800A priority
Priority to US612038 priority
Application filed by BHK Holding Ltd filed Critical BHK Holding Ltd
Priority to PCT/GB2000/003586 priority patent/WO2001023653A1/en
Publication of EP1216319A1 publication Critical patent/EP1216319A1/en
Application granted granted Critical
Publication of EP1216319B1 publication Critical patent/EP1216319B1/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04BKNITTING
    • D04B1/00Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
    • D04B1/10Patterned fabrics or articles
    • D04B1/12Patterned fabrics or articles characterised by thread material
    • DTEXTILES; PAPER
    • D03WEAVING
    • D03DWOVEN FABRICS; METHODS OF WEAVING; LOOMS
    • D03D15/00Woven fabrics characterised by the material or construction of the yarn or other warp or weft elements used
    • DTEXTILES; PAPER
    • D03WEAVING
    • D03DWOVEN FABRICS; METHODS OF WEAVING; LOOMS
    • D03D15/00Woven fabrics characterised by the material or construction of the yarn or other warp or weft elements used
    • D03D15/0027Woven fabrics characterised by the material or construction of the yarn or other warp or weft elements used using bicomponent threads
    • DTEXTILES; PAPER
    • D03WEAVING
    • D03DWOVEN FABRICS; METHODS OF WEAVING; LOOMS
    • D03D3/00Woven fabrics characterised by their shape
    • D03D3/02Tubular fabrics
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04BKNITTING
    • D04B1/00Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
    • D04B1/10Patterned fabrics or articles
    • D04B1/12Patterned fabrics or articles characterised by thread material
    • D04B1/123Patterned fabrics or articles characterised by thread material with laid-in unlooped yarn, e.g. fleece fabrics
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2201/00Cellulose-based fibres, e.g. vegetable fibres
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2331/00Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
    • D10B2331/02Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyamides
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2401/00Physical properties
    • D10B2401/06Load-responsive characteristics
    • D10B2401/063Load-responsive characteristics high strength
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2403/00Details of fabric structure established in the fabric forming process
    • D10B2403/01Surface features
    • D10B2403/011Dissimilar front and back faces
    • D10B2403/0114Dissimilar front and back faces with one or more yarns appearing predominantly on one face, e.g. plated or paralleled yarns
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00Medical; Hygiene
    • D10B2509/02Bandages, dressings or absorbent pads
    • D10B2509/022Wound dressings

Abstract

A composite fabric comprising a combination of a gel-forming yarn and a reinforcing yarn. A method of making a reinforced absorptive fabric comprising the steps of weaving, knitting or braiding together gel-forming yarn with reinforcing yarn, such that the network of reinforcing yarn provides structural integrity to the fabric independent of the gel-forming yarn. A composite fabric or structure may also comprise a composite yarn in which is incorporated both gel-forming fibre and reinforcing fibre. Gel-forming fabrics or structure may be made by first forming fabrics or structures of gel-forming fibre precursor and then converting the precursor to its gel-forming state.

Description

    FIELD OF INVENTION
  • The present invention pertains to fabrics that are capable of absorbing a relatively large quantity of a fluid. Certain embodiments of such fabrics are particularly useful for the control of bleeding.
  • BACKGROUND OF INVENTION
  • It is known to use, for various medical and other purposes, fibrous materials, including yarns, which gel when wet and which absorb body fluids. Such materials are used as swabs during surgery, as hemostatic agents and wound dressings. The problem with such materials is that they tend to become weak when wet. Structures formed from these materials tend to break or lose integrity upon absorption of blood or body fluids.
  • Among the materials used for this purpose are collagen, oxidized cellulose, calcium alginate and hemostatic gelatin. Such materials will be referred to generically herein as gel-forming materials and yarns made therefrom as gel-forming yarns.
  • One particular material of this kind is sodium carboxymethylcellulose (CMC), staple fibre forms of which are used in non-woven fabrics that are commonly used in post-trauma and post-surgical situations as wound dressings. CMC gels upon contact with water, blood or body fluids, and swells to absorb such materials. CMC also facilitates blood clotting while absorbing any exude and is, therefore, hemostatic. In addition, it is well known that CMC is hydroscopic so it does not readily dry into clotted blood, and therefore can be removed easily without causing re-bleeding. If it does dry, it can be easily re-gelled by wetting with water or saline solution.
  • A composite structure, incorporating gel-forming fibres and conventional textile fibres, is disclosed in international patent application, WO 98/46818. The materials described in WO 98/46818 as gel-forming fibres are essentially the same as those which are useful, in yarn form, in the present invention.
  • In the structure disclosed in WO 98/46818, the gel-forming fibres are said to be "laid-in" to a knitted fabric. Applicant believes, however, that a knitted structure as disclosed there would, to a significant degree, lose its physical integrity upon gelling of the gel-forming fibres and would not be suitable in an application in which the fabric is stretched when the gel forming fibres are gelled.
  • SUMMARY OF INVENTION
  • The present invention provides a composite knit, woven or braided fabric comprised of a combination of gel-forming yarn and reinforcing yarn, wherein the reinforcing yarn is knit, woven or braided such that the fabric is capable of retaining its structural integrity independent of the gel-forming yarn.
  • In one embodiment of the present invention, the gel-forming yarn is composed of a hemostatic material such as sodium carboxymethylcellulose (CMC).
  • Typically the reinforcing yarn is a thin strong synthetic material, such as nylon.
  • In the knit, woven or braided fabric of this invention, the gel-forming yarn may follow the same yarn path as some or all of the reinforcing yarn courses. The gel-forming yarn may also follow a different path by which it is laid in or interwoven with the reinforcing yarn.
  • In one form of the present invention, the fabric may be made by weaving, knitting or braiding a composite fabric comprised of reinforcing yarn and a gel-forming yarn such as oxidized cellulose or CMC. Alternatively, such a fabric may be made by weaving, knitting or braiding, with a reinforcing yarn, a cellulosic yarn, the woven, knit or braided structure being such that the structural integrity of the fabric is dependent on the reinforcing yarn only, and then converting the cellulosic yarn therein to oxidized cellulose or sodium carboxymethylcellulose.
  • This conversion process is conventional and requires only that the reinforcing yarn be resistant to chemical attack in the conversion process. The cellulosic yarn thus converted is in fact gel-forming, highly absorptive and may be hemostatic. In knit form, the resultant fluid absorbing fabric is stretchable, to the degree the reinforcing yarn and/or the structure of the fabric is stretchable. Such a fabric retains its structural integrity even when stretched and when the gel-forming yarn has absorbed water or blood or body fluid and formed a gel therewith.
  • This conversion process may be useful also with unreinforced knitted, woven or braided cellulosic fabric, that is cellulosic fabrics without reinforcing yarn, and to non-woven structures comprised of precursors of gel-forming fibres or yarns.
  • Still another form of reinforced gel-forming absorbent fabric, within the scope of this invention, may be made by forming the fabric or other structure with a composite yarn, the yarn itself comprising a composite or combination of gel-forming fibre (or a precursor thereof, convertible as described above) with a reinforcing fibre. Such a composite yarn may comprise a yarn spun from a combination of such fibres or a core spun yarn, wherein the core fibre is a continuous strand of a reinforcing filament, or filaments, made of a material such as nylon.
  • BRIEF DESCRIPTION OF DRAWINGS
  • Figure 1 is a diagrammatic view of one knitted embodiment of the present invention.
  • Figure 2 is a diagrammatic view of another knitted embodiment of the present invention.
  • DETAILED DESCRIPTION OF INVENTION
  • The present invention, in one embodiment, comprises a composite fabric, which retains its structural integrity while absorbing a large quantity of fluid, and particularly to such a fabric useful for the control of bleeding. One application for such a fabric is in an expandable hemostatic device for the control of bleeding in body cavities, as disclosed and claimed in a separate patent application of partial common inventorship herewith, U.S. Application Serial No. 09/406/166, filed September 27, 1999.
  • As used herein, the term "hemostatic" refers to a material that retards or prevents bleeding. Some gel-forming materials, such as CMC, are hemostatic. The term "reinforcing" yarn refers to a yarn that has greater tensile strength in a wet phase than a gel-forming yarn with which it is combined.
  • The word "yarn," as used herein, refers to an indefinite length of material suitable for weaving, knitting or braiding, typically comprised of one or more continuous strands of material or a multiplicity of relatively short length fibres spun into a fibre bundle of indefinite length, or some combination of continuous strands and spun fibres.
  • Gel-forming materials or yarns, of the type generally referred to herein, typically soften to form a gel or partially dissolve when brought into contact with a suitable liquid such as blood. Such a material absorbs liquid and will absorb many times its own weight. Certain gel-forming materials are referred to as hemostatic because they tend to cause blood to clot while absorbing any exudate. Hemostatic, gel-forming materials, such as CMC, are particularly useful for medical purposes wherein the absorption of body fluids is important. Such materials are also used during surgery, or other medical procedures, as hemostatic agents and wound dressings.
  • The composite fabric of the present invention comprises a reinforcing yarn woven, knitted or braided with a gel-forming yarn. Typically, the reinforcing yarn is a relatively strong synthetic material, with which the gel-forming yarn is placed side by side during the weaving, knitting or braiding of the gel-forming and reinforcing yarns into a woven, knitted or braided fabric. Alternatively, all or less than all of the yarn courses of the reinforcing yarn may be accompanied by gel-forming yarn. Alternatively also, still other yarn courses or picks of the woven or knitted fabric may comprise gel-forming yarn only, so long as the network of woven or knitted reinforcing yarn retains its structural integrity independent of the gel-forming yarn.
  • In general, it is preferred for present purposes to maximize the proportion of gel-forming yarn in the fabric and incorporate as little as possible of the reinforcing yarn, while still ensuring adequate strength in the fabric after the gel-forming yarns have gelled. As a practical matter, at least 5% (by weight) of reinforcing yarn is required but a larger proportion of reinforcing yarn may be used to yield a fabric of greater strength.
  • CMC, a preferred gel-forming material in the present invention, may be made by the chemical conversion of a variety of cellulosic materials, such as viscose rayon, cotton, etc. One cellulosic yarn suitable for the present invention is a Lyocell yarn. It is available from Spinneroff Streif AG, Zurichstrasse 170, Uathal, Switzerland. Lyocell is a solvent spun cellulose, produced from the natural cellulose in wood pulp by dissolution of the pulp in a solvent and then extruding the solution through a multiple-hole die, called a spinneret, to form a yarn comprised of a plurality of continuous strands. The solvent is vaporized in the process, leaving a continuous multi-filament yarn composed of pure cellulose.
  • The filaments in such a yarn may be chopped into staple form and spun into a yarn in a way similar to that used in processing cotton fibre.
  • In accordance with one aspect of the present invention, such an unconverted cellulose yarn is readily woven, knit or braided into a precursor fabric, from which the fabric of the present invention is made by conversion of the cellulose to sodium carboxymethylcellulose or to oxidized cellulose, in accordance with well-known techniques.
  • In the conversion of cellulose to sodium carboxymethylcellulose, less than all of the cellulose building blocks may be converted to the sodium carboxymethylcellulose form and the degree of this conversion will dictate the degree to which a resultant CMC yarn will absorb water and form a gel therewith. This proportion is sometimes referred to as the conversion factor. While the present invention is not limited to sodium carboxymethylcellulose of any particular conversion factor, such materials with a conversion factor of 50 to 70% are preferred in the fabric of the present invention.
  • Oxidized cellulose, which is conventionally used in knitted form as a hemostatic agent during surgery, may also be used in the reinforced fabric of the present invention and may also be converted (oxidized) after cellulosic yarn is first woven, knit or braided into a precursor fabric.
  • Yet another hemostatic material, useful in the present invention, is calcium alginate, which is a material derived from seaweed, and, in matted fibre form, is also used as a wound dressing. Other fibrous polysaccharides, with similar chemistry and properties to CMC, may also be used.
  • Combinations of different gel-forming agents may be used within the scope of the present invention. Such combinations may be made by forming a yarn from different gel-forming or hemostatic fibres and/or by weaving, knitting or braiding combinations of different gel-forming yarns.
  • In the case where a precursor fabric is first formed with cellulose yarn, and the knitted, woven or braided cellulose yarn is then converted to gel-forming oxidized cellulose or sodium carboxymethylcellulose, the reinforcing yarn must be non-reactive with the reactants and the products of the process of converting the cellulosic material into the gel-forming, chemically modified form thereof.
  • Referring to Figure 1, the step of weaving, knitting or braiding involves conventional methods, which are known. In accordance with the present invention, each of the multiple yarn end feeds to a weaving loom, knitting machine or braiding machine may comprise, in effect, two yarn ends, fed in parallel, one the gel-forming yarn (or a precursor yarn suitable for subsequent conversion to a gel-forming yarn), and one the reinforcing yarn. With a weft knit fabric constructed in this way as an example, the knit fabric product would include, as shown in Figure 1, a thin reinforcing yarn 2, combined in all yarn courses with a thicker (but weaker) yarn 1, which is either a gel-forming fibre or is convertible to a gel-forming yarn (i.e. a gel-forming yarn precursor).
  • In such a structure, at least some of the gel-forming yarn courses may be omitted, depending on the relative degree of strength and absorptive capacity desired. Shown in Figure 2 is another knit fabric of the present invention. Reinforcing yarns 3 are knit so as to provide structural integrity to the fabric, while gel-forming (or precursor to gel-forming) yarns 4 are inlaid therewith. The inlaying of gel-forming yarns 4 is such that even if the gel-forming yarns 4 are fully dissolved, the network of reinforcing yarns will maintain the structural integrity of the fabric.
  • Knit forms of the composite fabric of this invention have some inherent stretchability. In certain embodiments of the fabrics, such as those shown in Figures 1 and 2, still more stretchability may be provided. More specifically, the reinforcing yarn itself may be stretchable so that the fabric itself is more stretchable. This is particularly useful when the fabric is intended for disposition around a balloon-expanding device, as described in the above-referenced co-pending U.S. patent application. For that purpose, a tubular fabric is preferred.
  • In fact, one particularly effective use for the fabric of the present invention is as a hemostatic shroud covering an expansible device, adapted for disposition in a body cavity or passageway, such as a nasal passageway, to control bleeding therein, as disclosed in the above-referenced U.S. Patent Application Serial No. 09/406,166, filed September 27, 1999.
  • While the range of fabrics required for different applications is very wide, an exemplary fabric, made for use in a nasal hemostatic device, comprises a knit construction, as illustrated in Figure 1, knitted into a tubular form in accordance with well-known methods. In this exemplary fabric, a gel forming precursor yarn (12 tex lyocell spun yarn is knit together with a reinforcing yarn comprised of 17 decitex 3 filament nylon. The fabric structure is a plain weft, knitted in circular form with 36 needles. The loop length is 5 mm and the weight of the finished fabric is 1.6 grams per metre (wet relaxed and dried to normal moisture regain). The reinforcing yarn comprises about 12%, by weight, of this fabric before conversion of the Lyocell to CMC and about 11% after that conversion.
  • The conversion of the Lyocell in this exemplary fabric is accomplished by methods well known in the art.
  • While the nylon reinforcing yarn used in this embodiment would not be considered stretchable, the fabric structure itself is stretchable and deformable, that is it will expand in diameter at the expense of its length.
  • Apart from the composite fabric as described above, the present invention also includes the process of making a gel-forming or hemostatic structure, including a matted fibre or laid-in knit structure, as disclosed in the above-referenced WO 98/46818, by first forming the structure with gel-forming fibre precursors, such as cellulose fibre or yarn, and then converting the structure to the gel-forming state thereof, namely oxidized cellulose or CMC.
  • Still other composites and fabrics within the scope of this invention comprise a composite yarn, the structure of which includes both reinforcing fibres, such as nylon, and gel-forming fibres (or precursors thereof).
  • The most elementary method of combining two different fibres within one yarn is to simply spin the yarn from a mixture of the two fibres in staple form. However, this may lead to an overly weakened yarn once the gelling has taken place.
  • A preferred example of such a composite yarn is a core spun yarn, that is a yarn wherein staple fibres are spun around a preformed yarn. This preformed yarn may be another spun yarn, or, more commonly, a continuous filament yarn. This preformed yarn may comprise a reinforcing material, such as nylon. Gel-forming, or precursors of gel-forming, fibres comprise a second component of the final yarn product. The gel-forming fibres therein (converted from precursor materials either prior to or after spinning) provide absorptive and hemostatic capacity to the yarn and the reinforcing fibres or central filament of the preformed yarn provide strength. Such a yarn may be woven, knit or otherwise incorporated into a fabric or other structure, wherein fluid or blood absorption are important.
  • While the product and method of making the product of this invention have been described in connection with several specific embodiments, it should be understood that numerous modifications could be made by persons of skill in this art without departing from the true spirit and scope of the invention. Accordingly, the above description is intended to be merely illustrative and not limiting.

Claims (20)

  1. A composite knitted, woven or braided fabric comprising a combination of:
    yarn (1, 4) which is either gel-forming or is a precursor yarn, capable of being converted to a gel-forming yarn; said gel-forming yarn or gel-forming yarn precursor (1, 4) being woven, knitted or braided with a reinforcing yarn (2, 3), the knitting, weaving or braiding of such reinforcing yarn (2, 3) comprising a network capable of providing physical integrity to said fabric independent of said gel-forming yarn or gel-forming yarn precursor (1, 4).
  2. The fabric of Claim 1 wherein said gel-forming yarn precursor (1, 4) is a cellulosic yarn.
  3. The fabric of Claim 1 wherein said gel-forming yarn (1, 4) is comprised of sodium carboxymethylcellulose.
  4. The fabric of Claim 1 wherein said gel-forming yarn (1, 4) is selected from the group consisting of sodium carboxymethylcellulose, oxidized cellulose, and calcium alginate.
  5. The fabric of any one of Claims 1 to 4 wherein said reinforcing filament (2, 3) is a nylon continuous mono or multifilament yarn.
  6. The fabric of any one of Claims 1 to 5 comprising one or more yarns (1, 4) capable of gelling upon contact with liquid, and one or more reinforcing yarns (2, 3), wherein said reinforcing yarn (2, 3) has greater tensile strength than said gelling yarn (1, 4) in a wet phase, and wherein said fabric is highly absorbent to blood and body fluids.
  7. A method of making a composite fabric comprised of a combination of gel-forming yarn (1, 4) and reinforcing yarn (2, 3) said method comprising the steps of:
    weaving, knitting or braiding together a plurality of courses of said gel-forming (1, 4) and said reinforcing yarns (2, 3),
    said plurality of yarns including at least one said yarn having hemostatic properties (1, 4) and at least one said yarn (2, 3) having a tensile strength greater than the tensile strength of said hemostatic yarn in a wet phase, said higher strength yarn (2, 3) being woven, knit or braided so as to provide structural integrity to said fabric independent of said hemostatic yarn (1, 4).
  8. The method of Claim 7 wherein said yarn (1, 4) having hemostatic properties is converted cellulose yarn.
  9. The method of Claim 8 wherein said converted cellulose yarn (1, 4) is sodium carboxymethylcellulose, converted after the knitting, weaving or braiding of a cellulose precursor yarn.
  10. The method of Claim 8 wherein said cellulose yarn (1, 4) is oxidized to produce oxidized cellulose fibre.
  11. The method of Claim 10 wherein said cellulose yarn (1, 4) is oxidized after the step of said weaving, knitting or braiding.
  12. The method of Claim 7 wherein said yarn (1, 4) having hemostatic properties is calcium alginate.
  13. A precursor fabric capable of being converted into a composite woven, knitted or braided fabric of any one of Claims 1 to 6, said precursor fabric comprising a network of woven, knitted or braided yarns capable of retaining the structural integrity thereof in the presence of said selected fluid and, combined therewith, precursor yarn (1, 4) capable of being converted to gel-forming yarn (1, 4), which gel-forming yarn (1, 4) has a capacity to absorb said preselected fluid by forming a gel therewith.
  14. A method of making a fabric of any one of Claims 1 to 6 by first making a structure of a material including fibrous material which is chemically convertible to a gel-forming absorptive material (1, 4), and then chemically converting said material to its gel-forming, absorptive form (1, 4).
  15. A method, as recited in Claim 14, wherein said precursor material (1, 4) is a cellulosic yarn.
  16. A method, as recited in Claim 15, wherein said converted material (1, 4) is CMC.
  17. A method, as recited in any one of Claims 14 to 16, wherein the finished structure is a knitted fabric.
  18. A method, as recited in any one of Claims 14 to 16 wherein the finished structure is a woven fabric.
  19. A method, as recited in any one of Claims 14 to 16, wherein the finished structure is a braided fabric.
  20. A structure, as recited in Claims 17, 18 or 19 wherein the fabric is in a tubular form.
EP20000960844 1999-09-27 2000-09-19 Absorptive fabric Active EP1216319B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US40649099A true 1999-09-27 1999-09-27
US406490 1999-09-27
US61203800A true 2000-07-07 2000-07-07
US612038 2000-07-07
PCT/GB2000/003586 WO2001023653A1 (en) 1999-09-27 2000-09-19 Absorptive fabric

Publications (2)

Publication Number Publication Date
EP1216319A1 EP1216319A1 (en) 2002-06-26
EP1216319B1 true EP1216319B1 (en) 2004-04-07

Family

ID=27019535

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20000960844 Active EP1216319B1 (en) 1999-09-27 2000-09-19 Absorptive fabric

Country Status (9)

Country Link
EP (1) EP1216319B1 (en)
JP (1) JP2003510475A (en)
CN (1) CN1214141C (en)
AT (1) AT263858T (en)
AU (1) AU771967B2 (en)
CA (1) CA2384689C (en)
DE (1) DE60009727T2 (en)
ES (1) ES2222231T3 (en)
WO (1) WO2001023653A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0030794D0 (en) * 2000-12-16 2001-01-31 Hudson John O Medical device and use thereof
US8367570B2 (en) 2002-04-04 2013-02-05 The University Of Akron Mechanically strong absorbent non-woven fibrous mats
US7765647B2 (en) 2002-04-04 2010-08-03 The University Of Akron Non-woven fiber assemblies
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
GB2409162B (en) * 2004-10-06 2005-12-14 Bhk Holding Ltd Materials,methods,and apparatus for treating a body cavity
JP5133061B2 (en) 2004-10-20 2013-01-30 エシコン・インコーポレイテッドEthicon, Incorporated Enhanced absorbent multilayer hemostatic wound dressing and method of manufacture
WO2006044878A2 (en) 2004-10-20 2006-04-27 Ethicon, Inc. A reinforced absorbable multilayered fabric for use in tissue repair and regeneration
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
GB0513555D0 (en) * 2005-07-01 2005-08-10 Squibb Bristol Myers Co Carboxymethylated cellulosic wound dressing garment
GB0513552D0 (en) * 2005-07-01 2005-08-10 Squibb Bristol Myers Co Bandage
GB0525504D0 (en) 2005-12-14 2006-01-25 Squibb Bristol Myers Co Antimicrobial composition
US20090074837A1 (en) * 2007-09-19 2009-03-19 Ut-Battelle, Llc Bioresorbable Calcium-Deficient Hydroxyapatite Hydrogel Composite
GB0808376D0 (en) * 2008-05-08 2008-06-18 Squibb Bristol Myers Co Wound dressing
DE102008037888A1 (en) 2008-08-15 2010-02-25 Birgit Riesinger Wound care articles comprising textile ribbons having fibers with gel-forming properties and fibers having non-gelling properties
JP5259028B1 (en) * 2011-09-12 2013-08-07 グンゼ株式会社 Method for producing hydrophilic cellulose fiber
CN104024498B (en) * 2011-11-01 2017-08-22 布莱特维克公司 Wound dressing and available for the line in wound dressing
GB201120693D0 (en) * 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
US9402770B2 (en) 2011-12-09 2016-08-02 Covidien Antimicrobial non-adherent dressings and related methods therefor
US20130150764A1 (en) * 2011-12-09 2013-06-13 Tyco Healthcare Group Lp Non-Adherent Wound Dressings and Related Methods Therefor
US9125767B2 (en) 2011-12-21 2015-09-08 Kci Licensing, Inc. Wound filler having dynamic motion
CN103668617B (en) * 2012-08-31 2016-12-21 康力得生技股份有限公司 Natural polymer yarn and manufacture method, reticulated and application
JPWO2015099083A1 (en) 2013-12-25 2017-03-23 日産化学工業株式会社 Water dispersion that solidifies serum and blood
CN103741261B (en) * 2014-01-13 2016-05-04 大连工业大学 Calcium alginate/macrogol ester dual network phase-change energy-storage fibre and preparation method thereof
JP2016202255A (en) * 2015-04-15 2016-12-08 スリーエム イノベイティブ プロパティズ カンパニー Surface fastener female material, surface fastener, and absorbent good

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3561441A (en) * 1967-08-10 1971-02-09 Victor J Lombardi Surgical product for dressing and treating wounds, and method of manufacture
DE3100466A1 (en) * 1981-01-09 1982-09-02 Snia Viscosa Knitted garment and process for producing it
DE69221894D1 (en) * 1992-01-24 1997-10-02 Precis Nanterre Soc Dressing product with core of alginate fibers
GB9618565D0 (en) * 1996-09-05 1996-10-16 Bristol Myers Co Wound dressing
CA2256644C (en) * 1997-04-11 2006-05-23 Andrew D. Court Knitted wound dressings and method for making same
NL1005812C1 (en) * 1997-04-15 1997-06-04 Claus Jurgen Timmermans Super absorbent dressing.
GB9812329D0 (en) * 1998-06-08 1998-08-05 Courtaulds Plc Yarns and wound dressings containing the same

Also Published As

Publication number Publication date
CA2384689A1 (en) 2001-04-05
CA2384689C (en) 2009-05-12
CN1214141C (en) 2005-08-10
JP2003510475A (en) 2003-03-18
AU7301300A (en) 2001-04-30
CN1376221A (en) 2002-10-23
EP1216319A1 (en) 2002-06-26
ES2222231T3 (en) 2005-02-01
AT263858T (en) 2004-04-15
DE60009727D1 (en) 2004-05-13
DE60009727T2 (en) 2004-08-12
AU771967B2 (en) 2004-04-08
WO2001023653A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
US3087833A (en) Fibrous structures and methods of making the same
CA1308224C (en) Cellulosic fibre
FI103813B (en) cellulose fibers
US3865918A (en) Wet spinning cellulosic products
ES2320175T3 (en) Three-dimensional protesic fabric with reabsorbable dense face.
US20030138480A1 (en) Synthetic fibers for medical use and method of making the same
US20180015197A1 (en) Wound dressings, and yarn useful therein
EP1139946B1 (en) Multi-layered wound dressing
US7745681B1 (en) Nonwoven fabrics and their manufacture and use
FI87369B (en) Stabilizer TYG.
JP2006524117A (en) Arteriovenous grafts with the ability to seal themselves quickly after surgery
CA1304570C (en) Water absorbing rapidly shrinking fibers
JP2606803B2 (en) Orthopedic Canon Stay packaging tape
JP4823476B2 (en) Hemostasis wound dressing and method for making the same
CA2120736C (en) Collagen constructs
CN1046324C (en) High absorbency alginate fabric and method for its preparation
US3108357A (en) Compound absorbable prosthetic implants, fabrics and yarns therefor
EP0680344B1 (en) Wound dressings
US5133199A (en) Conformable stretch bandage
CA1047750A (en) Filaments of chemically modified cellulose fibers, method of making such filaments and webs and products formed therefrom
US4984570A (en) Knitted hydrophobic web wound dressing
JP4204498B2 (en) Compound twisted yarn
EP0783605B1 (en) Wound Dressing
EP0998313A1 (en) Composite prosthesis for preventing post-surgical adhesions and method for obtaining same
CA2179415C (en) Non-adherent wound dressing of gel-forming and textile fibres

Legal Events

Date Code Title Description
AX Request for extension of the european patent to:

Free format text: AL;LT;LV;MK;RO;SI

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17P Request for examination filed

Effective date: 20020308

17Q First examination report despatched

Effective date: 20030603

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HUDSON, JOHN OVERTON

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040407

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040407

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040407

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040407

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040407

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040407

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040407

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 60009727

Country of ref document: DE

Date of ref document: 20040513

Kind code of ref document: P

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040707

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040707

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040707

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040919

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040920

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20040407

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040930

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2222231

Country of ref document: ES

Kind code of ref document: T3

26N No opposition filed

Effective date: 20050110

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040907

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

PGFP Annual fee paid to national office [announced from national office to epo]

Ref country code: ES

Payment date: 20181001

Year of fee payment: 19

PGFP Annual fee paid to national office [announced from national office to epo]

Ref country code: DE

Payment date: 20190903

Year of fee payment: 20

Ref country code: IT

Payment date: 20190917

Year of fee payment: 20

Ref country code: FR

Payment date: 20190815

Year of fee payment: 20

PGFP Annual fee paid to national office [announced from national office to epo]

Ref country code: GB

Payment date: 20190920

Year of fee payment: 20